US Patent Issued to MEDINCELL on June 17 for "Long acting injectable formulation comprising risperidone and biodegradable polymers" (Israeli Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,851, issued on June 17, was assigned to MEDINCELL S.A. (Jacou, France).

"Long acting injectable formulation comprising risperidone and biodegradable polymers" was invented by Avia Merenlender Wagner (Binyamina, Israel), Anna Elgart Valitsky (Kfar-Saba, Israel) and Eran Harary (Netanya, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to methods of treating psychiatric diseases and disorders comprising administering to a subject in need thereof at a frequency of no more than once every 28 days an injectable formulation comprising risperidone, triblock and diblock copolymers wherein the concentration of the rispe...